Avient narrows FY25 adjusted EPS view to $2.77-$2.87 from $2.70-$2.94

Consensus $2.76. “Looking ahead to the second half of the year, we expect similar demand trends that we experienced in the first half,” said Jamie Beggs, senior VP and CFO, Avient (AVNT) Corporation. “We expect momentum from our high profit portfolios in defense and healthcare markets, along with disciplined cost controls and productivity initiatives, to contribute to continued margin expansion over the prior year. Accordingly, we are narrowing our full year guidance range for adjusted EBITDA to $545 to $560 million and adjusted EPS to $2.77 to $2.87.”